Zhejiang Ausun Pharmaceutical Co., Ltd.SSE: 603229

Announcement on Wholly-owned Subsidiary Obtaining Drug Registration Certificate for Entecavir Tablets

· Issued by Zhejiang Ausun Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Summary by 6ix AI

Zhejiang Ausun Pharmaceutical Co., Ltd. announced that its wholly-owned subsidiary has obtained a drug registration certificate for Entecavir Tablets, confirming its eligibility for production and sales.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Wholly-owned Subsidiary Obtaining Drug Registration Certificate for Entecavir Tablets

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Zhejiang Ausun Pharmaceutical Co., Ltd. on 6ix

Earlier from Zhejiang Ausun Pharmaceutical

Later from Zhejiang Ausun Pharmaceutical

All Zhejiang Ausun Pharmaceutical news releases